Announcements

May is Hepatitis Awareness Month

The month of May is designated as Hepatitis Awareness Month in the United States.  During May, the Centers for Disease Control and Prevention and its public health partners work to shed light on this hidden epidemic by raising awareness of viral hepatitis and encourage priority populations to get tested.  For more information about current ReACH Center hepatitis C screening and preventions projects please visit http://stophepatitisc.com/

ReACH Assistant/ Associate/Professor Opening

Please visit our Job Opportunities page for more information about this exciting opportunity! 

ReACH Scholar, Dr. Carlos Jaén named to the board of National Library of Medicine

ReACH Scholar Carlos Jaén, MD, PhD, professor and chair of family and community medicine in the Joe R. & Teresa Lozano Long School of Medicine, has been appointed to the board of regents of the National Library of Medicine of the National Institutes of Health. Dr. Jaén’s special interests include improving preventive care for individuals of all ages, preventing complications from chronic diseases like diabetes, high blood pressure and heart disease.

 

 

Contact Us

7411 John Smith Road

Suite 1050

San Antonio, TX

78229

 

Tel: 210-562-5551

Fax: 210-562-5560

Cancer Research

Sharon Cooper, Principal Investigator:
Texas Department of State Health Services. Cancer Record Occupation and Industry Coding Project, 2012-2013
 
Yuanyuan Liang, Co-Investigator:
 
Project #: 1 R01 CA138627
Funding Agency: NIH NCI
Title: Improving prostate biopsy efficiency: The finasteride challenge test
Status: Active
Period: 07/2010 - 06/2015
Role: Co-Investigator
Grant Detail: Study objective is to determine if a five alpha reductase challenge improves upon the performance of serum prostate specific antigen (PSA), Prostate cancer gene 3 (PCA3), ETS gene fusion, markers of gene methylation, digital rectal examination (DRE), and other measures of prostate cancer risk in men who are scheduled for prostate biopsy. Our hypothesis is that the rate and magnitude of the fall of serum PSA will be greater among men without prostate cancer than among those men who are ultimately found to have prostate cancer.
 
Project #: N/A
Funding Agency: CPRIT
Title: Salud San Antonio! A Clinical and Health Collaborative for Cancer Screening
Status: Active
Period: 03/2012 - 02/2015
Role: Co-Investigator
Grant Detail: The long-term goal of the Salud San Antonio program is to reduce breast, cervical, and colorectal cancer incidence, morbidity, and mortality among residents in the West and South sides of San Antonio, predominantly Latino areas of the city.
 
Period: 03/2012 - 02/2015
Role: Co-Investigator
Grant Detail: The long-term goal of the Salud San Antonio program is to reduce breast, cervical, and colorectal cancer incidence, morbidity, and mortality among residents in the West and South sides of San Antonio, predominantly Latino areas of the city.